LifeVantage Launches Complete TrueScience(TM) Skin Care Regimen
The full TrueScience skin care regimen consists of four products: TrueScience™ Ultra Gentle Facial Cleanser, TrueScience™ Perfecting Lotion, TrueScience™ Eye Corrector Serum, and TrueScience™ Anti-Aging Cream, which is an enhanced version of the company's existing anti-aging facial cream. The regimen has been tested in an independent third-party clinical study and has been shown to reduce the visible signs of aging by utilizing Nrf2 technologies to mitigate the visible effects of skin damage caused by oxidative stress. When used together, this regimen offers cumulative anti-aging benefits and provides protection against the environmental assault on the skin that consumers will be able to see and feel. Studies show that, in just four weeks, the skin appears renewed, visibly younger, brighter and more even-toned.
The products are available immediately and will be sold through the company's Distributor network and to Preferred Customers in all markets where
Dr.
About
Forward Looking Statements
This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as "believe," "hopes," "intends," "estimates," "expects," "projects," "plans," "anticipates," "look forward to" and variations thereof, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. Examples of forward-looking statements include, but are not limited to, statements we make regarding the success of our new line of skin care products. Such forward-looking statements are not guarantees of performance and the Company's actual results could differ materially from those contained in such statements. These forward-looking statements are based on the Company's
current expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. These risks and uncertainties include, among others, those discussed in greater detail in the Company's Annual Report on Form 10-K and the Company's Quarterly Report on Form 10-Q under the caption "Risk Factors," and in other documents filed by the Company from time to time with the
CONTACT: Investor Relations Contact:Source:Cindy England (801) 432-9036 Director of Investor Relations -or-John Mills (310) 954-1105 Partner,ICR, LLC Media Relations Contact:John Genna (801) 432-9172 VP Communications and Corporate Sponsorships
News Provided by Acquire Media